Author's response

Por Jeffers, Michael
Publicado em 1998

Purpura fulminans in a patient with mixed connective tissue disease

Por Murad, Aizuri A, Jeffers, Michael, Tobin, Anne-Marie, Connolly, Maureen
Publicado em 2013

Amplification of the HER2 gene in breast cancers testing 2+ weak positive by HercepTest immunohistochemistry: false‐positive or false‐negative immunohistochemistry?

Por Barrett, Ciara, Magee, Hilary, O'Toole, Denise, Daly, Sinead, Jeffers, Michael
Publicado em 2007

Pharmacologically enhanced expression of GPNMB increases the sensitivity of melanoma cells to the CR011‐vcMMAE antibody‐drug conjugate

Por Qian, Xiaozhong, Mills, Evan, Torgov, Michael, LaRochelle, William J., Jeffers, Michael
Publicado no Mol Oncol (2008)

The mutationally activated Met receptor mediates motility and metastasis

Por Jeffers, Michael, Fiscella, Michele, Webb, Craig P., Anver, Miriam, Koochekpour, Shahriar, Vande Woude, George F.
Publicado em 1998

Anti-apoptotic signaling by hepatocyte growth factor/Met via the phosphatidylinositol 3-kinase/Akt and mitogen-activated protein kinase pathways

Por Xiao, Guang-Hui, Jeffers, Michael, Bellacosa, Alfonso, Mitsuuchi, Yasuhiro, Vande Woude, George F., Testa, Joseph R.
Publicado em 2001

Differential effects of class I isoform histone deacetylase depletion and enzymatic inhibition by belinostat or valproic acid in HeLa cells

Por Dejligbjerg Marielle, Grauslund Morten, Litman Thomas, Collins Laura, Qian Xiaozhong, Jeffers Michael, Lichenstein Henri, Jensen Peter, Sehested Maxwell
Publicado em 2008-09-01

Activating mutations for the Met tyrosine kinase receptor in human cancer

Por Jeffers, Michael, Schmidt, Laura, Nakaigawa, Noboru, Webb, Craig P., Weirich, Gregor, Kishida, Takeshi, Zbar, Berton, Vande Woude, George F.
Publicado em 1997

Differential effects of class I isoform histone deacetylase depletion and enzymatic inhibition by belinostat or valproic acid in HeLa cells

Por Dejligbjerg, Marielle, Grauslund, Morten, Litman, Thomas, Collins, Laura, Qian, Xiaozhong, Jeffers, Michael, Lichenstein, Henri, Jensen, Peter Buhl, Sehested, Maxwell
Publicado em 2008

AKT1(E17K) mutation profiling in breast cancer: prevalence, concurrent oncogenic alterations, and blood-based detection

Por Rudolph, Marion, Anzeneder, Tobias, Schulz, Anke, Beckmann, Georg, Byrne, Annette T., Jeffers, Michael, Pena, Carol, Politz, Oliver, Köchert, Karl, Vonk, Richardus, Reischl, Joachim
Publicado no BMC Cancer (2016)

Image analysis as an adjunct to manual HER-2 immunohistochemical review: a diagnostic tool to standardize interpretation

Por Dobson, Lynne, Conway, Catherine, Hanley, Alan, Johnson, Alex, Costello, Sean, O’Grady, Anthony, Connolly, Yvonne, Magee, Hilary, O’Shea, Daniel, Jeffers, Michael, Kay, Elaine
Publicado em 2010

The von Hippel-Lindau Tumor Suppressor Gene Inhibits Hepatocyte Growth Factor/Scatter Factor-Induced Invasion and Branching Morphogenesis in Renal Carcinoma Cells

Por Koochekpour, Shahriar, Jeffers, Michael, Wang, Paul H., Gong, Changning, Taylor, Gregory A., Roessler, Lisa M., Stearman, Robert, Vasselli, James R., Stetler-Stevenson, William G., Kaelin, William G., Linehan, W. Marston, Klausner, Richard D., Gnarra, James R., Vande Woude, George F.
Publicado em 1999

Tumour pharmacodynamics and circulating cell free DNA in patients with refractory colorectal carcinoma treated with regorafenib

Por Wong, Andrea Li Ann, Lim, Joline Si Jing, Sinha, Arvind, Gopinathan, Anil, Lim, Robert, Tan, Chee-Seng, Soh, Thomas, Venkatesh, Sudhakar, Titin, Christina, Sapari, Nur Sabrina, Lee, Soo-Chin, Yong, Wei-Peng, Tan, David Shao Ping, Pang, Brendan, Wang, Ting-Ting, Zee, Ying-Kiat, Soong, Richie, Trnkova, Zuzana, Lathia, Chetan, Thiery, Jean-Paul, Wilhelm, Scott, Jeffers, Michael, Goh, Boon-Cher
Publicado no J Transl Med (2015)